ECDC surveillance report on Legionnaires’ disease in Europe in 2010
ECDC published its annual surveillance report on Legionnaires’ disease in Europe in 2010. In 2010, a total of 6 296 cases of Legionnaires’ disease were notified by EU Member States, Iceland and Norway, with a 11% increase from 2009. The majority of the cases were community-acquired, while around 20% were travel-associated.
ECDC published its annual surveillance report on Legionnaires’ disease in Europe in 2010.
In 2010, a total of 6 296 cases of Legionnaires’ disease were notified by EU Member States, Iceland and Norway, with a 11% increase from 2009. The majority of the cases were community-acquired, while around 20% were travel-associated.
The surveillance activity was carried out by the European Legionnaires’ Disease Surveillance Network (ELDSNet) and coordinated by ECDC. This is the second annual report presenting the analysis of Legionnaires’ disease (LD) surveillance data in Europe. Data were collected through two different schemes, the first scheme covering all cases of LD reported from ELDSNet members, while the second scheme covers all reported cases of travel-associated Legionnaires’ disease (TALD), including reports from countries outside the EU. This document is therefore the first annual report that includes all reported cases of LD and TALD.
Collecting data on TALD at EU-level is crucial to identify and tackle clusters of Legionnaires’ disease that may not have been identified at a national level, particularly because in Europe, notification rates and laboratory diagnostic practice highly differ among countries.
Legionnaires’ disease is a multisystem disease involving pneumonia. Humans are infected by inhalation of aerosols containing Legionella bacteria. The diagnosis relies on specific laboratory tests, and the disease is considered to be widely underreported, mainly because it is under diagnosed by clinicians and under-notified to national authorities. The ELDSNet should continue its efforts on improving notification in countries where under-ascertainment probably remains quite high, especially by raising awareness, providing laboratory support and training, and evaluating the surveillance systems in place.
Read the full report ‘Legionnaires’ disease in Europe – 2010’
Antimicrobial resistance and causes of non-prudent use of antibiotics in human medicine: results of the ARNA project
The final report of the EU-funded project “Antimicrobial Resistance and causes of Non-prudent use of Antibiotics” (ARNA) highlights that in Europe 7% of all antibiotics used in 2016 were taken without prescription; the two main sources being over-the-counter (OTC) sales and use of leftover antibiotics.Read more
Epidemiological update: Measles - monitoring European outbreaks, 14 July 2017
Romania has been experiencing a large outbreak of measles since February 2016. Cases continue to be reported despite ongoing response measures implemented at national level through reinforced vaccination activities. Between 1 January 2016 and 07 July 2017, Romania reported 7 647 measles cases, including 31 deaths.Read more
Monthly measles and rubella monitoring, surveillance data May 2017
ECDC reports the routine measles surveillance data submitted by the 30 EU/EEA countries on a monthly basis and publishes them as monthly epidemiological updates. This update covers the period Measles and rubella surveillance data from 1 June 2016 to 31 May 2017. In addition, ECDC is currently monitoring European measles outbreaks through epidemic intelligence on a weekly basis and publishing details in Weekly Epidemiological Updates and the Communicable Disease Threat Report (CDTR).Read more